M yocardial fibrosis is a pathological feature associated with cardiac hypertrophy, myocyte necrosis, and hypertension. 1 Components of the renin-angiotensin system, including ACE and angiotensin II (Ang II), have been implicated in the development of cardiac fibrosis.
1,2 Significantly, numerous studies have provided evidence for the presence of a local tissue ACE, and expression of ACE has been demonstrated in both rat 3, 4 and human 5, 6 cardiac tissues. Furthermore, the cardiac renin-angiotensin system has been shown to be functional in humans, 7 ACE being the predominant pathway for the local generation of Ang II in human cardiac tissues. 8 The microvascular endothelium is considered to be the main site of ACE expression in both rat 9, 10 and human 9, 11 hearts, although other cardiac cells may express the enzyme. ACE binding and immunostaining, for example, have been localized to interstitial cells at sites of myocardial infarction (MI) in the rat, 9, 10 and ACE expression has been demonstrated in isolated rat cardiac fibroblasts. 12 In contrast, immunohistochemical studies on human tissues have provided conflicting information concerning the cellular localization of ACE immunoreactivity after MI. 9 , 13 We have shown that interstitial cells in the failing human heart display ACE binding, albeit at a relatively low level compared with the vascular endothelium. 11 However, the expression of ACE in human cardiac fibroblasts is still uncertain. In addition, little is known about the regulation of fibroblast ACE activity, and possible regulatory factors include glucocorticoids and basic fibroblast growth factor (bFGF), both of which have been demonstrated to enhance ACE activity in other cell types. 14 Several studies have suggested that Ang II is a trophic agent with the ability to influence myocardial fibrosis 15 and modulate cardiac fibroblast growth and collagen synthesis. 16 -19 The effects of Ang II are mediated through specific receptors, AT 1 and AT 2 being the main subtypes. 20 Both receptors occur in rat 21 and human 11, 22 myocardium, whereas the AT 1 subtype predominates in isolated adult rat cardiac fibroblasts. 16, 17 The expression of angiotensin receptors in cultured human cardiac fibroblasts and the effects of Ang II on cell growth and collagen metabolism remain to be established.
In the present study, we have determined the expression and activity of ACE in isolated human ventricular and atrial fibroblasts, studied the effects of Ang II on cardiac fibroblast collagen synthesis and proliferation, and characterized the receptor subtype mediating such responses.
Methods

Materials
Human Ang II, platelet-derived growth factor AB (PDGF-AB), bFGF, dexamethasone, phorbol myristate acetate (PMA), DMEM, HBSS, FCS, PBS, L-glutamine, penicillin/streptomycin, HEPES, EDTA, SDS, BSA, trichloroacetic acid, and collagenase II were purchased from Sigma Chemical Co.
125 I-labeled ( 
Human Cardiac Fibroblast Culture and Characterization
Samples of left ventricular and atrial myocardium were obtained from recipient hearts (age range, 2 to 59 years, with dilated cardiomyopathy or ischemic heart disease) at the time of cardiac transplantation and stored at 4°C for Յ12 hours in HBSS containing 20 mmol/L HEPES (pH 7.4). Myocardium from the free walls of left ventricles and atria, dissected free of epicardial and valvular regions, was minced fine and incubated in a sterile-filtered dissociation solution containing collagenase II 1000 U/mL for 2 hours under shaking in a water bath at 37°C. After 1 hour, the mixture was passed through a syringe several times to aid cell dissociation and then incubated for another hour. Dispersed cells were filtered (100-m nylon mesh), washed in fibroblast growth medium, centrifuged (1200 rpm, 5 minutes), resuspended in growth medium, and incubated in 25-cm 2 plastic flasks in a humidified atmosphere of 5% CO 2 in air. Fibroblast growth medium (DMEM supplemented with L-glutamine 2 mmol/L, penicillin 100 U/mL, streptomycin 100 g/mL, and 20% FCS) was replaced every 3 days. Fibroblasts were identified by positive immunostaining for fibroblast-specific antigen, 24 prolyl-4-hydroxylase, vimentin, tubulin, and filamentous actin. No immunoreactivity for endothelial (CD31) and muscle (desmin) markers was exhibited. Varying proportions of cells displayed ␣-smooth muscle actin immunoreactivity, also a feature of cardiac fibroblasts in culture, 16 which may reflect either variation in myocardial scarring between patients or possible phenotypic transformation of some cells in culture. Human endothelial cells, isolated from unused portions of donor aorta and recipient coronary artery as previously described, 25 exhibited the endothelial cobblestone morphology and CD31 immunostaining. Cells of passages 1 through 6 were used for all experiments.
Expression of ACE and the AT 1 Receptor Genes
Expression of ACE and AT 1 receptor was confirmed by reverse transcription-polymerase chain reaction (RT-PCR) analysis. Total RNA was prepared from cell pellets according to the method of Chomczynski and Sacchi, 26 and 5 g was reverse transcribed into cDNA with random primers (In Vitrogen). Oligonucleotide primers were synthesized according to the nucleotide sequences and genomic organization of human AT 1 receptor and ACE genes. The AT 1 receptor primer sequences were 5Ј-GATGGGGAGCGGCT-GGAGCGG-3Ј (sense) and 5Ј-TGCCAAAGGGCCAGCGGTAT-TC-3Ј (antisense), the PCR amplimer spanning exons 1, 2, 3, 4, and 5 over a region of 755 bp. For human ACE, the sense primer was 5Ј-ACTGGTGGTATCTTCGAACC-3Ј and the antisense primer 5Ј-GACCATGTCCTTCAGCACC-3Ј, the PCR amplimer spanning a region of 296 bp. The RT-PCR reaction and analysis were carried out as previously described. 
11
Radioligand Binding to ACE and AT 1 Receptor
ACE Activity Assay
Confluent cardiac fibroblasts in 24-well plates were incubated in DMEM containing 0.4% FCS for 48 hours before assay for ACE activity or treatment with either PDGF-AB 15 ng/mL, bFGF 50 ng/mL, dexamethasone 100 nmol/L, or PMA 1 mol/L for 24 to 48 hours. Before assay, cells were rinsed with PBS and incubated in serum-free DMEM ( 
Collagen Synthesis and DNA Synthesis Assays
Collagen synthesis was assessed by measurement of the cellular uptake of [ 3 H]proline. Fibroblasts were seeded into 24-well plates at 3ϫ10 4 cells per well (1 mL/well) in growth medium and incubated overnight. Cells were then incubated in DMEM containing 0.4% FCS for 48 hours before addition of Ang II 1 nmol/L to 10 mol/L. For experiments using selective antagonists, the cells were incubated with either losartan 10 mol/L or PD123319 1 mol/L for 1 hour before addition of Ang II and remained present throughout the experiment. [ 3 H]Proline was added to each well at a final concentration of 1 Ci/mL, and cells were incubated for 48 hours. After incubation, the supernatant in each well was replaced with ice-cold 10% trichloroacetic acid for 20 minutes at 4°C. The acid-precipitable material was rinsed with deionized water, then solubilized in 0.25 mL of 0.3 mol/L NaOH-0.1% SDS at 37°C for 2 hours. The cell lysate was added to 3 mL of liquid scintillant, and the incorporated radioactivity (cpm) was measured. The same protocol was used for assessing DNA synthesis, except that [methyl-
3 H]thymidine incorporation between 20 and 24 hours was measured, in response to Ang II 10 nmol/L to 10 mol/L and PDGF-AB 15 ng/mL.
Measurement of Intracellular Calcium Concentration
Cardiac fibroblasts on glass coverslips were loaded with the calcium indicator fura 2-AM 1 mol/L for 30 minutes at room temperature in Krebs-Henseleit buffer containing (in mmol/L) NaCl 120, KCl 4.8, MgSO 4 1.2, KH 2 PO 4 1.2, NaHCO 3 25, glucose 25, CaCl 2 1.3, and HEPES 25 (pH 7.4), and 0.1% BSA. Coverslips were then placed in a temperature-controlled holder (34°C) and mounted onto the stage of an epifluorescence microscope (Zeiss Axiovert 35). Cells were challenged with Ang II 1 mol/L and monitored visually over time as previously described. 28 When used, losartan 10 mol/L and PD123319 1 mol/L were present at all stages of the experiment. The intracellular calcium concentration ([Ca 2ϩ ] i ) was determined from fluorescence values by the formula described by Grynkiewicz et al.
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Statistics
Data are presented as meanϮSEM. Multiple groups of data underwent a 1-way ANOVA followed by Bonferroni t test. Student's t test 
Results
Expression of AT 1 Receptor and ACE mRNA and Radioligand Binding
Specific PCR products corresponding to human AT 1 receptor and ACE cDNA sequences were generated from both atrial and ventricular fibroblasts (Figure 1) . Expression of the AT 1 receptor gene displayed alternative splicing of the 5Ј untranslated exons, with 2 transcripts being detected, one encoding exons 1 and 5 (466-bp PCR product) and the other exons 1, 2, and 3 (551-bp PCR product).
Atrial and ventricular fibroblasts exhibited specific 8 )Ang II and Ang II, as well as by losartan, and nonspecific binding represented Ͻ10% of total binding (Figure 2B) . Cardiac fibroblasts also exhibited specific binding of the radiolabeled ACE inhibitor [
125 I]-351A, albeit at a lower level than that displayed by endothelial cells (Figure 3) , and this was abolished in the presence of either EDTA (data not shown) or 1 mol/L lisinopril. 
ACE Activity of Cardiac Fibroblasts
Effect of Ang II on Collagen and DNA Synthesis and Intracellular Calcium Concentration
Cardiac fibroblasts responded to Ang II 1 nmol/L to 10 mol/L with a concentration-dependent increase in nmol/L to 10 mol/L exhibited no effect on [methyl-3 H]thymidine incorporation at 24 hours, whereas PDGF-AB caused a 7-fold increase (data not shown). Neither was any stimulation of DNA synthesis observed between 18 and 42 hours, which was measured to account for possible delayed mitogenesis.
Human cardiac fibroblasts responded to Ang II with a rapid increase in [Ca 2ϩ ] i (basal, 56Ϯ1 nmol/L to Ang II, 355Ϯ24 nmol/L; PϽ0.001; nϭ66 cells) ( Figure 6 ). The peak response occurred Ϸ16 seconds after stimulation, returning to baseline levels thereafter ( Figure 6B ). The Ang II-induced calcium increases were completely inhibited by pretreatment with 
Discussion
We have demonstrated expression of both ACE and the AT 1 receptor subtype in cultured human cardiac fibroblasts and have shown that the AT 1 receptor subtype mediates Ang II-induced increases in collagen synthesis and intracellular calcium in these cells. Together, these findings implicate ACE and Ang II in the development of myocardial fibrosis, independent of changes in hemodynamics.
The demonstration of ACE expression and activity in human cardiac fibroblasts supports the findings of several recent studies. In the rat heart, ACE expression has been detected at sites of fibrosis after Ang II infusion 15 and after MI, 10 as well as in myofibroblasts isolated from cardiac scar tissue. 12 Expression of ACE has also been detected in human cardiac tissues 5, 30 and a correlation found between the levels of ACE and fibrillar collagen type I mRNA. 30 More specifically, increased ACE activity has been found in aneurysmal left ventricular tissue 31 and ACE immunoreactivity localized to myocytes as well as other cell types, including fibroblasts, adjacent to scar tissue 13 in patients after MI. In the present study, no differences were detected between the level of ACE activity in fibroblasts cultured from failing (dilated cardiomyopathy or ischemic heart disease) and normal donor hearts. However, we cannot exclude the possibility that the culture conditions influenced the level of ACE expression. Conversely, apparent differences in ACE activity and binding between cultured human coronary endothelial cells and cardiac fibroblasts correspond with results obtained in intact tissue sections. Previous observations from this group as well as others indicate that although ACE binding 11 and immunostaining 13 are localized predominantly to the microvascular endothelium in the failing and normal human heart, both are detectable on other cell types in the human myocardium, including myocardial, interstitial, and fibroblast-like cells. 11, 13 Although the potential of human cardiac fibroblasts to generate Ang II may be less than that of endothelial cells, it should not be underestimated and may be particularly significant in the diseased heart, such as after MI, in which enzyme-bearing cells are prevalent at sites of scarring and in the border zone adjacent to scar tissue. 2, 13 Among potential modulators of ACE activity, dexamethasone, bFGF, and PMA induced an increase in cardiac fibroblast ACE activity. Dexamethasone has previously been shown to stimulate ACE activity in rat aortic smooth muscle cells, 32 and the effective concentration used in this study is equivalent in glucocorticoid potency to levels of cortisol elevated in human plasma during physiological stress in vivo. 33 The stimulatory effect of bFGF suggests that the growth factor may influence ACE activity at sites of myocardial injury, where it can be released from damaged cells. 34 The positive effect of PMA may be attributed to either short-term activation or long-term downregulation of protein kinase C (PKC) in cardiac fibroblasts. Together, these results provide evidence for the dynamic regulation of ACE activity and potential autocrine control of cardiac fibroblasts.
Ang II induced a net stimulation of collagen synthesis, this being in agreement with the results of previous studies on isolated human 19 and rat cardiac fibroblasts. 16, 18 The Ang II-induced collagen synthesis and intracellular calcium transients in human cardiac fibroblasts were both shown to occur via the AT 1 receptor, the expression of which was confirmed by RT-PCR analysis and radioligand binding. The AT 2 receptor antagonist PD123319 had no apparent effect on either 125 I-(S 1 ,I 8 )Ang II binding, collagen synthesis, or intracellular calcium transients, which suggests the absence of AT 2 receptors. These results contrast with those obtained by ourselves and others in tissue sections and myocardial membrane preparations, indicating the presence of both receptor subtypes in human myocardium and the predominance of the AT 2 subtype in regions of fibrosis. 11, 22, 35, 36 This apparent discrepancy between in vivo and in vitro findings probably reflects changes in the proportion of Ang II receptors, particularly downregulation of AT 2 receptors, after isolation of cells and in response to culture conditions. 16, 17, 37, 38 Thus far, AT 2 receptor expression has not been demonstrated in human primary cell cultures, and the relative instability of AT 2 receptor expression in isolated cells represents a significant limitation of in vitro investigations. Knowledge about the function of the AT 2 receptor is limited to studies using animal models and isolated rodent cells, in which the receptor mediates effects such as inhibition of collagen synthesis 39 and DNA synthesis, 40 thereby opposing responses mediated by the AT 1 subtype. Recently, however, blockade of the AT 2 receptor has been shown to inhibit DNA synthesis in interstitial cells after MI in the rat. 41 Therefore, although the present findings implicate the AT 1 receptor in human cardiac fibrosis, the potential involvement of the AT 2 receptor in vivo cannot be excluded and requires further investigation.
In conclusion, the present results indicate that cardiac fibroblasts represent a site for the local generation and action of Ang II in the human heart and therefore may contribute to the development of cardiac fibrosis. This highlights the potential of ACE inhibition and AT 1 receptor antagonism in strategies for prevention as well as possibly regression of fibrosis.
